Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.31 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24723618 | 0.89 | ALDH1A1 (0.38) | ALDH1A1CYP3A4HPGDHSD17B10 | |
| SCHEMBL22891548 | 0.81 | MEN1 (0.39) | ALDH1A1CYP3A4HPGDHSD17B10 | |
| SCHEMBL25569221 | 0.81 | ALDH1A1 (0.34) | ALDH1A1CYP3A4HPGDHSD17B10 | |
| SCHEMBL24723470 | 0.77 | ALDH1A1 (0.36) | SLC6A2SLC6A4SLC6A3GSTP1ALDH1A1 | |
| SCHEMBL23637460 | 0.77 | ALDH1A1 (0.40) | SLC6A2SLC6A4SLC6A3CNR1GSTP1 | |
| SCHEMBL25924022 | 0.76 | GSTP1 (0.40) | SLC6A2SLC6A4SLC6A3GSTP1ALDH1A1 | |
| SCHEMBL23814589 | 0.76 | MEN1 (0.35) | SLC6A2SLC6A4SLC6A3SIRT2GSTP1 | |
| SCHEMBL22891429 | 0.75 | ALDH1A1 (0.42) | ALDH1A1CYP3A4HPGDHSD17B10 | |
| SCHEMBL21658420 | 0.75 | MEN1 (0.36) | SIRT2GSTP1ALDH1A1HPGDHSD17B10 | |
| SCHEMBL21658270 | 0.75 | MEN1 (0.36) | SIRT2GSTP1ALDH1A1HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11563182-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-01-24 | — | — | US | disclosed |
| US-20220376185-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2022-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220376185-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | TCF7, MCM7, LUC7L2 | SLC6A2 3000/4885SLC6A4 2819/4885SLC6A3 3932/4885 |
| US-11563182-B2 | Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof | TCF7, MCM7, LUC7L2 | SLC6A2 3000/4885SLC6A4 2819/4885SLC6A3 3932/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.